Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 1/20 | 0.50 |
| ▸ | LTB4R | Q15722 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13015602 | 0.91 | PLA2G2A (0.50) | PLA2G2A | |
| SCHEMBL9284533 | 0.85 | — | — | |
| SCHEMBL9281256 | 0.85 | — | — | |
| SCHEMBL9221172 | 0.84 | — | — | |
| SCHEMBL3266907 | 0.84 | PLA2G2A (0.39) | PLA2G2A | |
| SCHEMBL3266909 | 0.84 | PLA2G2A (0.39) | PLA2G2A | |
| SCHEMBL2023186 | 0.81 | — | — | |
| SCHEMBL202015 | 0.81 | — | — | |
| SCHEMBL457832 | 0.81 | — | — | |
| SCHEMBL202012 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7868174-B2 | Form of a benzenesulfonamide derivative | PLIVA-ISTRAZIVANJE I RAZVOJ D.O.O. (HR) | 2011-01-11 | — | — | US | disclosed |
| US-7868174-B2 | Form of a benzenesulfonamide derivative | PLIVA-ISTRAZIVANJE I RAZVOJ D.O.O. (HR) | 2011-01-11 | — | — | US | disclosed |
| US-20080009629-A1 | Novel Form of a Benzenesulfonamide Derivative | PLIVA-ISTRAZIVANJE I RAZVOJ D.O.O. (HR) | 2008-01-10 | — | — | US | disclosed |
| US-20080009629-A1 | Novel Form of a Benzenesulfonamide Derivative | PLIVA-ISTRAZIVANJE I RAZVOJ D.O.O. (HR) | 2008-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080009629-A1 | Novel Form of a Benzenesulfonamide Derivative | ADH1A, ADH5, ADH1C | PLA2G2A 3553/4885LTB4R 3924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.